RewordedRisk Factors
Although we believe that any amount received by us in exchange for our stock would qualify for the exemption under Section 1032 of the Internal Revenue Code, because it is not entirely clear whether a forward equity agreement qualifies as a "securities futures contract," the U.S. federal income tax treatment of any cash settlement payment we receive is uncertain.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
This may be the result of various factors, including, but not limited to: changes in the economy; the availability and cost of capital at favorable rates; increases in property taxes, utilities and other operating expenses; changes to facility-related healthcare regulations; changes in interest rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to re-lease space at similar rates as vacancies occur; the Company's ability to timely reinvest proceeds from the sale of assets at similar yields; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; and other financial, legal and operational matters.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
There can be is no assurance that the Company will recover unpaid rent from Prospect or be able to timely relet the remaining Prospect leased space related to any rejected leases. that was not assumed by Hartford Health.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, the deterioration of economic conditions, including supply chain constraints, that could result from another pandemic may ultimately decrease occupancy levels and average rent per square foot across the Company's portfolio as tenants reduce or defer their spending.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
In addition, changes in federal and state legislation and regulation on climate change could result in increased capital expenditures to improve energy efficiency of our existing properties and could require the Company to spend more on development and redevelopment properties without a corresponding increase in revenue.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
Trends in the healthcare service industry industry, including the impact of the One Big Beautiful Bill Act passed during 2025 that is subject of ongoing analysis, may negatively affect the demand for the Company’s properties, lease revenues and the values of its investments.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
The Company incurred impairment charges of $249.9 $361.1 million in 2024, associated with 2025, related to completed or planned disposition activity. dispositions, changes in holding periods or changes in property use.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
As of December 31, 2024, 2025, the Company had investment concentrations of greater than 5% of its total investments in the Dallas, TX (8.5%), (9.5%), Seattle, WA (6.1%), Houston, TX (5.4%), (6.0%), and Seattle, WA (5.2%) Charlotte, NC (5.4%) markets.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
Prospect leases leased approximately 80,912 square feet of space from the Company, accounting for approximately $2.9 million of annual rental revenue. Company.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
As of December 31, 2024, 2025, the Company had investments of $473.1 $453.6 million in unconsolidated joint ventures with unrelated third parties comprised of 63 properties 61 properties, excluding held for sale properties, and seven parking garages.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
If this such an initiative had passed, it would have ended could end or reduce the beneficial effect of Proposition 13 for the Company's properties, and property tax expense could have increase substantially, adversely affecting the Company's cash flow from operations and net income.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedRisk Factors
Such increases in the cost of capital could adversely impact our ability to finance operations, acquire and develop properties, and refinance existing debt.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
•In March 2025, the Company executed a mezzanine loan receivable agreement with a maximum loan commitment of $8.5 million. As of December 31, 2025, the Company had funded the full $8.5 million under this agreement.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
•In April 2025, a mortgage loan receivable of $37.7 million maturing in February 2026 was repaid in full.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
•In December 2025, the Company received $5.8 million as payment towards the principal balance of its mortgage loan that matured on December 22, 2024,
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
6The Company sold six MOBs in El Paso, TX, four MOBs in Indianapolis, IN, two MOBs in each of Chicago, IL, Cincinnati, OH, Des Moines, IA, Fort Wayne, IN, Minneapolis, MN and Pittsburgh, PA; and one MOB in each of Detroit, MI, Las Vegas, NV and Salt Lake City, UT to a single buyer in a single transaction.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
On December 17, 2025, the Company renewed its ATM equity offering program to sell shares of the Company's common stock from time to time in at-the-market sales transactions. The Company entered into equity distribution agreements with various sales agents having an aggregate offering price of up to $1.0 billion. As of December 31, 2025, there has been no activity under the program.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
During the year ended December 31, 2025, the Company repaid in full a mortgage note payable bearing interest at a rate of 4.25% that encumbered a 45,157 square foot property in California.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
During the year ended December 31, 2025, the Company repaid its Senior Notes due 2025 at maturity including $250 million of principal and $4.8 million of accrued interest.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
In February 2026, the Company entered into a commercial paper dealer agreement to issue short-term commercial paper notes up to $600.0 million, with maturities up to 364 days. The program is back-stopped by the Unsecured Credit Facility. The notes will be issued at par less a discount representing an interest factor, or if interest bearing, at par.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
As previously disclosed, Prospect filed petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in January of 2025. Prospect leased approximately 80,912 square feet of space from the Company. In October of 2025, a subsidiary of Hartford Health was selected as the successful bidder for the Prospect assets associated with the Company’s Prospect leases. The Company signed direct leases with Hartford Heath totaling 65,477 square feet effective January 1, 2026 and retained certain sublet in additional spaces. There is no assurance that the Company will be able to timely relet the remaining Prospect leased space that was not assumed by Hartford Health.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
During the year ended December 31, 2025, the Company recorded approximately $0.5 million in debt extinguishment costs related to the Unsecured Credit Facility, which replaced the Company's prior credit facility.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
During 2025, the Company recorded approximately $4.3 million from Accumulated other comprehensive income ("AOCI") to other expense related to ineffectiveness and subsequent termination of eight interest rate swaps. See Note 10 to the Consolidated Financial Statements in this report for more details regarding the Company's derivative accounting.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
AddedMD&A
In addition, the Company recognized income of approximately $0.8 million primarily due to a Federal ERC program (Employee Retention Credit) providing cash payment for employee retention during the COVID-19 pandemic totaling $4.4 million, net of a charge for a merger-related transfer tax charge that was finalized during the fourth quarter of 2025 totaling $3.6 million.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RemovedMD&A
As described in Item 1. Business above and elsewhere in this report, on July 20, 2022, Legacy HR and Legacy HTA completed a merger between the companies in which Legacy HR merged with and into a wholly-owned subsidiary of Legacy HTA, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA. Immediately following the Merger, Legacy HTA changed its name to “Healthcare Realty Trust Incorporated.” For accounting purposes, the Merger was treated as a “reverse acquisition” in which Legacy HR was considered the acquirer. Accordingly, the information discussed in this section reflects, for periods prior to the closing of the Merger, the financial condition and results of operations of Legacy HR, and for periods from the closing of the Merger, that of the Company.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
In 2024, the Company's investment in unconsolidated joint ventures increased by $172.7 million, as a result of the Company's contribution of medical outpatient properties to two joint ventures in which it holds a 20% interest.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
•$52.4 million toward first generation tenant improvements and planned capital expenditures for acquisitions;
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
On June 24, 2024, the Company's two mezzanine loans in Texas with a total principal balance of $54.1 million matured. On July 15, 2024, the senior lender on the construction mortgage loans associated with the underlying project initiated foreclosure proceedings to the borrower. In the third quarter of 2024, the Company recorded an allowance for credit loss of $46.8 million to cover the entire carrying amount for these loans. The Company had
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
previously placed the mezzanine loans on non-accrual status in 2023. In the fourth quarter of 2024, the underlying project was sold, and the Company received $4.0 million as consideration for its mezzanine loan interests. The Company no longer has a mezzanine loan position in connection with the project.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
In 2024, the Company placed one of its real estate notes receivable with a principal balance of $31.2 million on non-accrual status. The Company determined that the risk of credit loss was no longer remote and recorded a credit loss reserve of $16.8 million including $0.5 million of accrued interest in 2024. In January 2025, the underlying real estate collateral was sold and the Company received $14.9 million towards the principal balance of this loan.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
1The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Raleigh, NC, New York, NY, Philadelphia, PA, Atlanta, GA, Austin, TX, Miami, FL, Denver, CO, Memphis, TN, Indianapolis, IN, and Honolulu, HI; two MOBs in Los Angeles; three MOBs in Houston, TX and Dallas, TX; and five in Seattle, WA. Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $584.9 million.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
2The Company sold seven MOBs in Greensboro, NC and two non-clustered single-tenant MOBs in Raleigh, NC to a single buyer in a single transaction.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
3The Company contributed the following medical outpatient properties to a joint venture in which the Company retained 20% ownership: one in each of Dallas, TX, San Antonio, TX and Atlanta, GA; and two MOBs in each of Nashville, TN and Denver, CO. Sale price and square footage reflect the total sale price paid by the joint venture and total square footage of the property. The net proceeds to the Company related to these dispositions totaled $148.9 million.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
5The Company sold an MOB that was included in a consolidated joint venture in which the Company held a 63% ownership interest. Proceeds include the Company's pro-rata share of the purchase price as well as amounts due to the Company by the joint venture.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
The following table details the mortgage note repayment activity for the year ended December 31, 2024:(dollars in millions) TRANSACTION DATE PRINCIPAL BORROWING (REPAYMENT) ENCUMBERED SQUARE FEET CONTRACTUAL INTEREST RATE Mortgages repaid at maturity: West Hills, CA 1/6/2024 $ (11.3) 63,012 4.77% Atlanta, GA 2/1/2024 (5.6) 40,324 4.12% Minnesota 9/1/2024 (7.0) 64,143 4.15% Total repayments $ (23.9) 167,479 4.44%
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RemovedMD&A
3Debt instruments assumed as part of the Merger with Legacy HTA on July 20, 2022. The amounts shown represent fair value adjustments.
Read it in 10-K Feb 19, 2025 at sec.govopen_in_new
RewordedMD&A
YEAR ENDED DECEMBER 31, Amounts in thousands, except per share data 2025 2024 2023 2022 Net (loss) income loss attributable to common stockholders $ (246,071) $ (654,485) $ (278,261) $ 40,897 Net (loss) income loss attributable to common stockholders per diluted share 1 $ (0.71) $ (1.81) $ (0.74) $ 0.15 Gain on sales of real estate assets (235,389) (104,684) (77,546) (270,271) Impairment of real estate properties 361,090 249,909 149,717 54,427 Real estate depreciation and amortization 586,146 690,988 738,526 459,211 Non-controlling loss from operating partnership units (3,497) (9,149) (3,426) (5) Unconsolidated JV depreciation depreciation, amortization and amortization impairment 27,769 20,678 18,116 12,722 FFO adjustments $ 736,119 $ 847,742 $ 825,387 $ 256,084 FFO adjustments per common share - diluted $ 2.08 $ 2.29 $ 2.15 $ 1.01 FFO attributable to common stockholders $ 490,048 $ 193,257 $ 547,126 $ 296,981 FFO attributable to common stockholders per common share - diluted $ 1.38 $ 0.52 $ 1.43 $ 1.17 — Transaction costs 2,029 3,122 2,026 3,229 Merger-related costs 2 — — (1,952) 103,380 Lease intangible amortization (1,350) (2,054) 860 1,028 Non-routine tax and legal costs/forfeited earnest money received matters (118) 1,077 175 771 Debt financing costs 2 5,107 237 (62) 3,145 Restructuring and severance-related charges 26,318 29,852 1,445 — Credit losses and gains (losses) on other assets, net 3 3,508 59,707 8,599 — Impairment of goodwill — 250,530 — — Merger-related fair value of debt instruments 42,593 40,667 42,885 21,248 Unconsolidated JV normalizing items 4 811 390 389 330 Normalized FFO adjustments $ 78,898 $ 383,528 $ 54,365 $ 133,131 Normalized FFO adjustments per common share - diluted $ 0.22 $ 1.04 $ 0.14 $ 0.52 Normalized FFO attributable to common stockholders $ 568,946 $ 576,785 $ 601,491 $ 430,112 Normalized FFO attributable to common stockholders per common share - diluted $ 1.61 $ 1.56 $ 1.57 $ 1.69 Non-real estate depreciation and amortization other amortization, net 6,114 1,478 2,566 2,217 Non-cash interest amortization, net 5 5,126 5,101 4,968 5,129 Rent reserves, net 952 714 3,163 516 Straight-line rent, net (29,392) (27,254) (32,592) (20,124) Stock-based compensation 13,609 14,036 13,791 14,294 Unconsolidated JV non-cash items 6 (1,420) (923) (1,034) (1,206) Normalized FFO adjusted for non-cash items $ 563,935 $ 569,937 $ 592,353 $ 430,938 2nd generation tenant improvements (47,438) (69,445) (66,081) (33,620) Leasing commissions paid (31,664) (47,450) (36,391) (22,929) Building capital (36,531) (33,934) (49,343) (48,913) FAD $ 448,302 $ 419,108 $ 440,538 $ 325,476 FFO weighted average common shares outstanding - diluted 7 354,454 369,767 383,381 254,622
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
AS OF DECEMBER 31, 2024 2025 Dollars and square feet in thousands PROPERTY COUNT GROSS INVESTMENT 1 SQUARE OCCUPANCY FEET Same store properties 556 473 $ 10,810,884 31,850 89.8% 9,172,301 26,303 92.2% Joint venture same store properties 29 322,639 1,636 89.2% 28 313,552 1,532 90.1% Wholly owned and joint venture acquisitions 33 172,330 2,388 94.3% 30 183,779 2,193 95.3% Wholly owned and joint venture development re/development completions 5 191,113 553 57.7% 4 139,279 332 60.8% Wholly owned and joint venture redevelopments 25 545,331 1,874 63.0% Planned Dispositions 3 50,245 144 58.3% re/developments 27 796,431 2,371 70.0% Total 651 562 $ 12,092,542 38,445 88.2% 10,605,342 32,731 90.4% Joint venture properties 65 556,897 4,253 87.4% 63 608,367 4,113 89.7% Total wholly-owned real estate properties 586 499 $ 11,535,645 34,192 88.3% 9,996,975 28,618 90.5%
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
During 2024, the year ended December 31, 2025, the Company repaid its $350 the $300 million Unsecured Term Loan, Loan due 2025 January 2026, the $200 million Unsecured Term Loan due January 2026, and recognized the $150 million Unsecured Term Loan due June 2026 and recorded approximately $0.2 $0.5 million of accelerated amortization expense included in the loss on extinguishment of debt.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
During the first quarter of 2024, the The Company determined that the carrying value of its single reporting unit exceeded estimated fair value and therefore recorded a $250.5 million full impairment of its goodwill, which is recorded as a non-cash charge in “Impairment of goodwill” in the consolidated statements Consolidated Statement of operations. Operations for the year ended December 31, 2024.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Accordingly, as permitted under Rule 13-01(a)(4)(vi) of Regulation S-X, the Company has excluded the summarized financial information for the OP because the assets, liabilities, and results of operations of the OP are not materially different than the corresponding amounts in the Company's Consolidated Financial Statements and management believes such summarized financial information would be repetitive and would not provide incremental value to investors.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The Company recorded impairment charges totaling $361.1 million and $249.9 million million, respectively, for the year years ended December 31, 2024 2025 and December 31, 2024, related to real estate properties sold and other long-lived assets. properties with changes in the expected holding periods.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Other operating income increased $1.7 $9.1 million, or 9.8%, from 47.3%, for the year ended December 31, 2025, compared to the prior year primarily as a result of income from management fees. fees related to unconsolidated joint ventures and managed properties.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
The In addition, the Company expensed costs related to the pursuit of acquisitions developments totaling $1.0 million, $1.1 million, and dispositions totaling $1.7 million, $0.8 million and $1.0 million for the years ended December 31, 2024, 2023 2025, 2024 and 2022, 2023, respectively.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
During 2024, In January 2026, the Company repurchased 30.8 2.9 million shares of its common stock at an average price of $16.56 $17.27 per share for a total of $509.8 million. $50.0 million resulting in $450.0 million of authorized share repurchases remaining.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
These transactions yielded net cash proceeds of $1.2 approximately $1.0 billion, net of $67.3 approximately $77.6 million of closing costs and related adjustments adjustments, and $172.7 $11.8 million of retained joint venture interests. in Company financed notes.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Additionally, In addition, the Company recorded $59.5 $1.6 million of in credit loss reserves on its relating to a mortgage note receivables notes receivable and a $4.1 $1.9 million fair value adjustment for an equity investment in other assets.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
RewordedMD&A
Impairment of real estate assets in 2024 totaling approximately $249.9 million is associated with related to completed or planned disposition activity. dispositions, changes in holding periods or changes in property use.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new
Quiet changesMD&A
However, during During the first quarter of 2024, the Company experienced a sustained decline in the price per share of its common stock, which was identified as an indicator of goodwill impairment.
Read it in 10-K Feb 13, 2026 at sec.govopen_in_new